98 hændelser, når erythropoiesestimulerende stoffer (ESA' er) blev administreret for at tilstræbe et hæmoglobinniveau, som var højere end 12 g/ dl (7, 5 mmol/ l).
98 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion.